Our writer explains why this FTSE 250 stock could still continue to provide growth and returns despite already being on a good run of late. The post Up 75% in 5 years, I reckon this FTSE 250 still has lots to give! appeared first on The Motley Fool UK.
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
Spire Healthcare Group ( LON:SPI ) Full Year 2023 Results Key Financial Results Revenue: UK£1.36b (up 13% from FY...